Authorities in Abu Dhabi have warned the public against using certain brands of cough syrups, manufactured in India, after they have been linked to child deaths in Gambia.
Taking to their official social media handles, the Department of Health — Abu Dhabi (DoH) confirmed that the four products by New Delhi-based Maiden Pharmaceuticals Limited were not sold anywhere in the UAE but warned the public, who may have obtained the products, not to use them.
They "contain contaminated ingredients, according to the World Health Organisation (WHO)", the authority added.
In the eventuality it was consumed, the public have been advised to seek medical help if they show any "side-effects".
The Department of Health — Abu Dhabi (DoH) has confirmed that these four products by Maiden Pharmaceuticals Limited are not available across all healthcare sector in the Emirate as they contain contaminated ingredients, according to the World Health Organization (WHO). pic.twitter.com/wBLNlBQRSU
— دائرة الصحة - أبوظبي (@DoHSocial) October 14, 2022
It comes after India said it's "seriously investigating" the deaths of 70 children in Gambia in the wake of a report that provisionally linked the fatalities to the cough syrups.
UAE sends humanitarian aid to earthquake-hit Colombia
UAE calls for global action to combat extremism and hate speech
Four UAE aid convoys deliver 781 tonnes of supplies to Gaza
Etihad Rail launches cargo service from Fujairah to Industrial City of Abu Dhabi
H.H. Sheikh Hamdan announces new Acting Director General of Dubai Ruler's Court
RTA completes works on Oud Metha, Al Asayel Streets development project
UAE President, Indian PM discuss stronger bilateral ties
